Bonneau D, Souied E, Gerber S, Rozet J M, D'Haens E, Journel H, Plessis G, Weissenbach J, Munnich A, Kaplan J
Service de Génétique, INSERM U393, Hôpital des Enfants Malades, Paris, France.
J Med Genet. 1995 Dec;32(12):951-3. doi: 10.1136/jmg.32.12.951.
Autosomal dominant optic atrophy (OPA, MIM 165500) is an eye disease causing a variable reduction of visual acuity with an insidious onset in the first six years of life. It is associated with a central scotoma and an acquired blue-yellow dyschromatopsia. A gene for dominant optic atrophy (OPA1) has recently been mapped to chromosome 3q in three large Danish pedigrees. Here, we confirm the mapping of OPA1 to chromosome 3q28-qter by showing close linkage of the disease locus to three recently reported microsatellite DNA markers in the interval defined by loci D3S1314 and D3S1265 in four French families (Zmax = 5.13 at theta = 0 for probe AFM 308yf1 at locus D3S1601). Multipoint analysis supports the mapping of the disease gene to the genetic interval defined by loci D3S1314 and D3S1265. The present study provides three new markers closely linked to the disease gene for future genetic studies in OPA.
常染色体显性遗传性视神经萎缩(OPA,MIM 165500)是一种眼部疾病,会导致视力在出生后的头六年内逐渐隐匿性下降。它与中心暗点和后天性蓝黄色色盲有关。最近,在三个丹麦大家族中,一个导致显性视神经萎缩的基因(OPA1)被定位到3号染色体长臂。在此,我们通过在四个法国家族中显示疾病位点与位于D3S1314和D3S1265位点所界定区间内的三个最近报道的微卫星DNA标记紧密连锁,证实了OPA1基因位于3号染色体长臂28区至末端(在D3S1601位点,探针AFM 308yf1在θ = 0时Zmax = 5.13)。多位点分析支持将疾病基因定位到由D3S1314和D3S1265位点所界定的遗传区间。本研究提供了三个与疾病基因紧密连锁的新标记,用于未来OPA的基因研究。